These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23291367)

  • 1. The association between cystatin C and incident type 2 diabetes is related to central adiposity.
    Reutens AT; Bonnet F; Lantieri O; Roussel R; Balkau B;
    Nephrol Dial Transplant; 2013 Jul; 28(7):1820-9. PubMed ID: 23291367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients.
    Lee SH; Park SA; Ko SH; Yim HW; Ahn YB; Yoon KH; Cha BY; Son HY; Kwon HS
    Metabolism; 2010 Feb; 59(2):241-6. PubMed ID: 19765773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of cystatin C predict the metabolic syndrome: the prospective Malmö Diet and Cancer Study.
    Magnusson M; Hedblad B; Engström G; Persson M; Nilsson P; Melander O
    J Intern Med; 2013 Aug; 274(2):192-9. PubMed ID: 23414447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of glycemia, body size, insulin resistance and the risk of hypertension in Mauritius.
    Boyko EJ; Shaw JE; Zimmet PZ; Chitson P; Tuomilehto J; Alberti KG
    J Hypertens; 2008 Sep; 26(9):1742-9. PubMed ID: 18698207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of Association of Cystatin C With Kidney and Cardiovascular Outcomes by Obesity.
    Chen DC; Scherzer R; Ix JH; Kramer HJ; Crews DC; Nadkarni G; Gutierrez O; Bullen AL; Ilori T; Garimella PS; Shlipak MG; Estrella MM
    Am J Kidney Dis; 2024 Apr; 83(4):489-496.e1. PubMed ID: 37866793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort.
    André P; Balkau B; Born C; Charles MA; Eschwège E;
    Diabetologia; 2006 Nov; 49(11):2599-603. PubMed ID: 16969645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediating effects of inflammatory biomarkers on insulin resistance associated with obesity.
    Wexler DJ; Hu FB; Manson JE; Rifai N; Meigs JB
    Obes Res; 2005 Oct; 13(10):1772-83. PubMed ID: 16286525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of glucose metabolism, smoking and cardiovascular risk factors with incident peripheral arterial disease: the DESIR study.
    Tapp RJ; Balkau B; Shaw JE; Valensi P; Cailleau M; Eschwege E;
    Atherosclerosis; 2007 Jan; 190(1):84-9. PubMed ID: 16674960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiposity and incident diabetes within 4 years of follow-up: the Guangzhou Biobank Cohort Study.
    Xu L; Lam TH; Jiang CQ; Zhang WS; Jin YL; Zhu T; Zhu F; Thomas GN; Cheng KK
    Diabet Med; 2017 Oct; 34(10):1400-1406. PubMed ID: 28477424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD36 (sCD36) clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes risk.
    Handberg A; Norberg M; Stenlund H; Hallmans G; Attermann J; Eriksson JW
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1939-46. PubMed ID: 20139232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated cystatin C concentration and progression to pre-diabetes: the Western New York study.
    Donahue RP; Stranges S; Rejman K; Rafalson LB; Dmochowski J; Trevisan M
    Diabetes Care; 2007 Jul; 30(7):1724-9. PubMed ID: 17456840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal waist circumference and the prediction of children's metabolic syndrome.
    Hirschler V; Roque MI; Calcagno ML; Gonzalez C; Aranda C
    Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1205-10. PubMed ID: 18056567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome in obese Thai children and adolescents.
    Iamopas O; Chongviriyaphan N; Suthutvoravut U
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S126-32. PubMed ID: 22043765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.
    Snijder MB; Heine RJ; Seidell JC; Bouter LM; Stehouwer CD; Nijpels G; Funahashi T; Matsuzawa Y; Shimomura I; Dekker JM
    Diabetes Care; 2006 Nov; 29(11):2498-503. PubMed ID: 17065691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired fasting glucose, ancestry and waist-to-height ratio: main predictors of incident diagnosed diabetes in the Canary Islands.
    de León AC; Coello SD; González DA; Díaz BB; Rodríguez JC; Hernández AG; Aguirre-Jaime A; Pérez Mdel C
    Diabet Med; 2012 Mar; 29(3):399-403. PubMed ID: 21883429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescreening tools for diabetes and obesity-associated dyslipidaemia: comparing BMI, waist and waist hip ratio. The D.E.S.I.R. Study.
    Balkau B; Sapinho D; Petrella A; Mhamdi L; Cailleau M; Arondel D; Charles MA;
    Eur J Clin Nutr; 2006 Mar; 60(3):295-304. PubMed ID: 16278693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hip circumference and height on incident diabetes: results from 6-year follow-up in the Tehran Lipid and Glucose Study.
    Bozorgmanesh M; Hadaegh F; Zabetian A; Azizi F
    Diabet Med; 2011 Nov; 28(11):1330-6. PubMed ID: 21627688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress.
    Oliveira SR; Simão AN; Kallaur AP; de Almeida ER; Morimoto HK; Lopes J; Dichi I; Kaimen-Maciel DR; Reiche EM
    Nutrition; 2014 Mar; 30(3):268-73. PubMed ID: 24484677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.